Washington, Sept 26 : Researchers in Portugal have found that a specific mutation of the COX2 gene may play a role in the onset of ovarian cancer, escalating a woman’s chances of developing the disease.
The discovery means that it might be possible to use non-steroidal anti-inflammatory drugs (NSAIDs), such as aspirin and ibuprofen, which are used already for other conditions, to prevent ovarian cancer developing in women with the COX2 mutation.